Business

VSEE Health, Inc. Delivers Robust Q3 2025 Revenue Growth Amid Telehealth Expansion: Total Revenues Reach $3.98 Million, Up 19% Year-Over-Year

SAN JOSE, CALIFORNIA / ACCESS Newswire / November 17, 2025 /VSee Health, Inc.(Nasdaq:VSEE), a pioneering provider of AI-powered telehealth solutions and high-acuity virtual care services, today announced its financial results for the third quarter ...

articleVsee Health, Inc.November 17, 20258/news/vsee-health-inc-delivers-robust-140000235
VSEE Health, Inc. Delivers Robust Q3 2025 Revenue Growth Amid Telehealth Expansion: Total Revenues Reach $3.98 Million, Up 19% Year-Over-Year

About this update from Vsee Health, Inc.

SAN JOSE, CALIFORNIA / ACCESS Newswire / November 17, 2025 / VSee Health, Inc. (Nasdaq:VSEE), a pioneering provider of AI-powered telehealth solutions and high-acuity virtual care services, today announced its financial results for the third quarter ended September 30, 2025, as detailed in its Form 10-Q filed with the SEC on November 14, 2025. In Q3 2025, VSee achieved total revenues of $3.98 million, a 19% increase from $3.35 million in the prior-year period, fueled by heightened demand for its integrated telehealth and professional services. Year-to-date through nine months, revenues climbed to $10.69 million, up 60% from $6.69 million in the comparable 2024 period, reflecting the full impact of the iDoc acquisition and expanded hospital partnerships. Gross margins remained resilient at 52%, supporting scalable growth as the company advances its pipeline of multi-year contracts projected to add millions in annualized recurring revenue. Key Financial and Operational Highlights for Q3 2025: Pro Forma Financial Results The unaudited pro forma financial information in the tables below summarizes the combined results of VSee Health's operations and iDoc's operations through September 30, 2025 Management Summary "Q3 2025 marks a critical milestone in VSEE's ascent as a telehealth leader, with revenue growth validating our focus on high-margin, AI-enhanced solutions that address clinician burnout and care access gaps," said Dr. Milton Chen and Dr. Imo Aisiku, Co-Chief Executive Officers of VSEE Health. "Our platform's seamless integrations with EHR systems and remote monitoring tools are empowering hospitals to optimize workflows, while our telehealth care expertise is capturing a larger share of the $455 billion federal telehealth opportunity. Despite macroeconomic headwinds, our 70% reduction in operating cash use year-to-date demonstrates prudent execution. With a robust pipeline and FedRAMP unlocking government deals, we're poised for profitability and exponential upside for our investors. VSEE's dual-segment model-Healthcare Technology and Telehealth Services-continues to thrive, with the Technology segment generating $6.12 million YTD (up 11% YoY) from subscriptions and engineering fees, and Telehealth contributing $4.57 million from patient and institutional services. As the telehealth sector grows at a 23.84% CAGR...

View stock analysis, news, and events for Vsee Health, Inc.

VSee